Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session - ACM Research (NASDAQ:ACMR), Argo Blockchain (NASDAQ:ARBK)

Gainers

Losers

Also Check This Out Wall Street Starts 2023 On Positive Note

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Gainers

Horizon Global Corporation (NYSE:HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Jasper Therapeutics, Inc. (NASDAQ:JSPR) gained 257% to $1.70 after the company announced clinical data from a Phase I/II trial of briquilimab as a conditioning treatment in sickle cell disease and beta thalassemia.
ReShape Lifesciences Inc. (NASDAQ:RSLS) shares jumped 142.3% to $16.34. Reshape Lifesciences recently announced a 1-for-50 reverse stock split.
Lucira Health, Inc. (NASDAQ:LHDX) surged 68% to $0.1875 after the company announced it submitted an Emergency Use Authorization application to the FDA for OTC use of its COVID-19 & Flu test.
Swvl Holdings Corp. (NASDAQ:SWVL) shares gained 43% to $0.1958 after the company reported commencement of strategic review process.
Vivos Therapeutics, Inc. (NASDAQ:VVOS) jumped 41% to $0.5678. Vivos Therapeutics recently posted a Q3 loss of $0.26 per share.
EpicQuest Education Group International Limited (NASDAQ:EEIQ) gained 40.1% to $3.0962.
Scilex Holding Company (NASDAQ:SCLX) jumped 40.1% to $5.59.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) surged 33.8% to $0.6690.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) gained 33.4% to $5.76. Aurinia said LUPKYNIS® (voclosporin) patent challenge settlement has been reached with Sun Pharmaceuticals.
Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) rose 33.3% to $0.28. Navidea Biopharmaceuticals announced the notice of allowance for U.S. patent application for key component of the company's cancer immunotherapy pipeline.
Chemomab Therapeutics Ltd. (NASDAQ:CMMB) gained 32% to $4.24 after the company reported top-line results from the CM-101 Phase 2a liver fibrosis biomarker trial in NASH patients. The trial met its primary endpoint.
RedHill Biopharma Ltd. (NASDAQ:RDHL) jumped 29% to $0.1810 after the company announced publication of data from the Phase 2 data study of RHB-107 in non-hospitalized COVID-19 patients. The study met the primary endpoint of safety and tolerability.
ACM Research, Inc. (NASDAQ:ACMR) gained 28.7% to $9.92 after the company issued FY23 revenue guidance above estimates.
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) gained 27.7% to $6.52.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) rose 25.2% to $1.1098. Sorrento Therapeutics, last month, received FDA clearance to initiate clinical trials with a next generation mRNA vaccine against omicron SARS-CoV-2 virus.
180 Life Sciences Corp. (NASDAQ:ATNF) shares gained 24% to $4.2009.
Dada Nexus Limited (NYSE:DADA) jumped 21.6% to $8.48.
Boxed, Inc. (NYSE:BOXD) gained 20% to $0.2346.
Gorilla Technology Group Inc. (NASDAQ:GRRR) shares gained 18% to $9.57 after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal.
T Stamp Inc. (NASDAQ:IDAI) gained 15% to $0.5887.
NaaS Technology Inc. (NASDAQ:NAAS) jumped 14.9% to $4.47. NaaS Technology appointed Alex Wu as its Chief Financial Officer, effective January 15, 2023.
Getaround, Inc. (NYSE:GETR) rose 14.3% to $0.7481 after gaining more than 30% on Friday. Piper Sandler recently initiated coverage on Getaround with an Overweight rating and announced a price target of $1.5.
Bilibili Inc. (NASDAQ:BILI) gained 14.3% to $27.08.
IM Cannabis Corp. (NASDAQ:IMCC) gained 13.1% to $1.12.
GDS Holdings Limited (NASDAQ:GDS) jumped 12.5% to $23.20.
Mullen Automotive, Inc. (NASDAQ:MULN) shares rose 8% to $0.3089 after gaining over 8% on Friday.
Cosmos Health Inc. (NASDAQ:COSM) rose 8% to $4.93. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 7.9% to $0.2169. Novo Integrated Sciences recently announced receipt of notice from Nasdaq.
XPeng Inc. (NYSE:XPEV) rose 7.7% to $10.72. XPeng sold 11,292 units for December and 22,204 units for the fourth quarter.
Cellectis S.A. (NASDAQ:CLLS) rose 7.1% to $2.25 after gaining around 8% on Friday.
Li Auto Inc. (NASDAQ:LI) rose 3.8% to $21.17. Li Auto said it delivered 21,233 vehicles in December, marking a record monthly performance. In the fourth quarter, the company sold 46,319 cars.

Losers

Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares fell 20.7% to $0.3243. Dermata Therapeutics shares jumped over 100% on Friday after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
SoundHound AI, Inc. (NASDAQ:SOUN) dropped 19% to $1.43 after climbing around 72% on Friday.
Inter & Co, Inc. (NASDAQ:INTR) fell 17.7% to $1.9501.
Argo Blockchain plc (NASDAQ:ARBK) fell 17.6% to $0.8897 after jumping around 19% on Friday. Argo Blockchain recently entered into definitive agreements with Galaxy Digital Holdings, under which an Argo subsidiary will sell its Helios facility in Dickens County, Texas for $65 million.
Mammoth Energy Services, Inc. (NASDAQ:TUSK) dropped 17.3% to $7.15.
Valens Semiconductor Ltd. (NYSE:VLN) fell 17% to $4.4800.
Palisade Bio, Inc. (NASDAQ:PALI) fell 16.4% to $4.3494. Palisade Bio recently announced $2.5 million registered direct offering and concurrent private placement priced above market under Nasdaq rules.
PDS Biotechnology Corporation (NASDAQ:PDSB) dropped 15.3% to $11.18. PDS Biotech announced exclusive global license agreement for investigational IL-12 tumor-targeted cytokine from Merck KGaA, Darmstadt, Germany.
Prelude Therapeutics Incorporated (NASDAQ:PRLD) fell 13.9% to $5.20.
BioVie Inc. (NASDAQ:BIVI) fell 13.7% to $6.70.
Fuwei Films (Holdings) Co., Ltd. (NASDAQ:RTC) fell 12.7% to $7.88.
Arqit Quantum Inc. (NASDAQ:ARQQ) fell 11.9% to $3.18.
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shares fell 11.3% to $33.83 after gaining over 53% on Friday. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
Korea Electric Power Corporation (NYSE:KEP) shares fell 10.4% to $7.74.
Tesla, Inc. (NASDAQ:TSLA) fell 10.3% to $110.54 after the company reported fourth-quarter deliveries that came in below market estimates. The company delivered more than 405,278 cars in the fourth quarter, and produced over 439,000. This represented a 31.33% year-over-year rise and a 17.87% sequential growth. The consensus estimate for Q4 deliveries compiled by Tesla’s investor relations was 417,957 units.
ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 9.8% to $2.11 after jumping 18% on Friday.
Nu Holdings Ltd. (NYSE:NU) fell 8.2% to $3.7392.
Silo Pharma, Inc. (NASDAQ:SILO) fell 6.3% to $3.15. Silo Pharma, on Friday, reported interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents.